MedTrace Logo

Hydrophilic Acrylic Intraocular Lens

NCT00708331 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-02-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of Hydrophilic Acrylic Intraocular Lens after cataract surgery

Conditions

  • Cataract Extraction

Interventions

DEVICE

2 HEMA Hydrophilic Acrylic Intraocular Lens

2 HEMA Hydrophilic Acrylic Intraocular Lens implanted into the posterior capsule following cataract surgery for patient life duration.

Sponsors & Collaborators

  • EyeKon Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • James Garvey, M.D.

  • David C Brown, M.D. · Eye Centers of Florida

  • Michael S Korenfeld, M.D. · Comprehensive Eye Care LTD

  • James E Croley, M.D. · Cataract and Refractive Institute of Florida

  • Larry Perich, D.O. · The Perch Eye Center

  • Thomas L Croley, M.D. · Central Florida Eye Institute

  • Farrell C Tyson, M.D · Cape Coral Eye Center

  • James P Gills, M.D. · St. Lukes Cataract and Laser Center

  • Robert Weinstock, M.D · The Eye Institute of West Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Primary Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00708331 on ClinicalTrials.gov